DTS-201 sodium
DTS-201 sodium (CPI-0004Na) is a doxorubicin peptide prodrug activated by tumor-specific endopeptidases. It has shown promising antitumor activity in preclinical in vivo models, including xenografts of prostate, breast, and lung cancers, supporting its investigation for targeted chemotherapy.
Product Specifications
Field of Research
Metabolism Research
Molecular Weight
1034.05
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog